Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4(+)CD25(+) T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-gamma, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4(+) T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, even within Tregs the intensity of FOXP3 expression can change, with naive or resting populations of Tregs expressing lower levels of FOXP3 than activated Tregs [379, 380].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
The cited source says what the claim attributes to it.
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 2×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression ( 26 , 27), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression (26, 27 ), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundTNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Cited by
Items 301–400 of 875
Podestà, M. A., Binder, C., Sellberg, F., DeWolf, S., Shonts, B. A., Ho, S., Obradović, A., Waffarn, E., Danzl, N. M., Berglund, D., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15533 · Cited by 57
Amer, E. M., Saber, S. H., Markeb, A. A., Elkhawaga, A. A., Mekhemer, I. M. A., Zohri, A.-N. A., Abujamel, T. S., Harakeh, S., & Abd-Allah, E. A. (2021) · Molecules · doi:10.3390/molecules26082113 · Cited by 59
“The i mune-modulatory effects of β-glucan were evaluated using phorbol-12-myriste13-acetate (PMA) as a positive control [27] and non-treated peripheral blo d mononuclear cells (PBMCs) media as a negative control.”
Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction
Niu, J., Jiang, C., Li, C., Liu, L., Li, K., Jian, Z., & Gao, T. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1025-3 · Cited by 55
“Even in T cells, Foxp3 expression does not automatically lead to acquisition of full regulatory activity since human T cells can transiently induce Foxp3 expression without acquisition of Treg function [ 28 ].”
BackgroundZhou, L., Fu, J., Lu, Y., Fu, B., Wang, C., An, L., Wang, X.-Z., Zeng, Z., Zhou, C., Yang, Y., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0243-3 · Cited by 52
“Because CD25 and FoxP3 are also expressed in activated conventional effector T cells [23], we further performed detection of the CD4CD127CD25 regulatory T cells before and after therapy.”
Dexamethasone upregulates FOXP3 expression without increasing regulatory activity
Prado, C., Gómez, J. M. F., López, P., de Paz, B., Gutiérrez, C., & Suárez, A. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.06.013 · Cited by 51
Iwase, H., Kobayashi, T., Kodera, Y., Miwa, Y., Kuzuya, T., Iwasaki, K., Haneda, M., Katayama, A., Takeda, A., Morozumi, K., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181ffbab4 · Cited by 56
“Thus, Foxp3 is not an exclusive marker of regulatory capability, because it has been shown that most human T cells transiently express Foxp3 during activation (13).”
BackgroundBenkert, T. F., Dietz, L., Hartmann, E., Leich, E., Rosenwald, A., Serfling, E., Buttmann, M., & Berberich‐Siebelt, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052208 · Cited by 50
“Enrichment could also be detected for FOXP3, which is the key transcription factor in regulatory T cells, but also indicative of activation in human effector T cells [33].”
BackgroundInfluentialCappellano, G., Ploner, C., Lobenwein, S., Sopper, S., Hörtnagl, P., Mayerl, C., Wick, N., Pierer, G., Wick, G., & Wolfram, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192108 · Cited by 53
Su, L. F., del Alcazar, D., Stelekati, E., Wherry, E. J., & Davis, M. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611723113 · Cited by 51
“However, because activated T cells in humans may transiently express Foxp3 (23, 24), we sought to confirm Treg characteristics of tetramer-labeled T cells by response to T-cell stimulation.”
BackgroundMuratori, L., & Longhi, M. S. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.016 · Cited by 53
McMurchy, A. N., Gillies, J. K., Allan, S., Passerini, L., Gambineri, E., Roncarolo, M. G., Bacchetta, R., & Levings, M. K. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.001 · Cited by 50
Self-citationRetargeting of Human Regulatory T Cells by Single-Chain Bispecific Antibodies
Koristka, S., Cartellieri, M., Theil, A., Feldmann, A., Arndt, C., Stamova, S., Michalk, I., Töpfer, K., Temme, A., Kretschmer, K., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101760 · Cited by 50
“Our observations of increased levels of these markers in Tregs after activation are in accordance with experiments in which aCD3/CD28-coated beads were used for Treg stimulation, resulting in increased FOXP3, CD25, CTLA-4, and CD69 expression levels in activated Tregs (29).”
ResultGilbert, R. M., Zhang, X., Sampson, R. D., Ehrenstein, M. R., Nguyen, D. X., Chaudhry, M., Mein, C. A., Mahmud, N., GALATOWICZ, G. E., Tomkins‐Netzer, O., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00907 · Cited by 54
“Visually significant cataract (%) – 2 (15) 9 (24)”
Mizuno, T., Suzuki, R., Umeki, S., & Okuda, M. (2009) · Journal of Veterinary Medical Science · doi:10.1292/jvms.001561 · Cited by 49
“Foxp3 and cell surface antigens such as CD25, CTLA-4, and GITR are induced in human CD4+CD25– T cells by in vitro stimulation with antiCD3 and antigen presenting cells (APCs) resulting in regulatory phenotypes of these cells [1, 14].”
BackgroundResultten Brinke, A., Marek-Trzonkowska, N. M., Mansilla, M. J., Turksma, A. W., Piekarska, K., Iwaszkiewicz‐Grześ, D., Passerini, L., Locafaro, G., Puñet‐Ortiz, J., van Ham, S. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01870 · Cited by 51
“However, these examples also indicate that dye proliferation assay can be a valuable tool to better dissect the effect of a given therapy, since in combination with gene profile or phenotypical analysis (i.e., FOXP3 expression or intracytoplasmic staining for cytokines) can help to grasp the mechanism underlying toler…”
BackgroundInfluentialSelf-citationForkhead transcription factors in chronic inflammation
Peng, S. L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.10.013 · Cited by 52
Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function
Gootjes, C., Zwaginga, J. J., Roep, B. O., & Nikolić, T. (2024) · Cells · doi:10.3390/cells13110941 · Cited by 53
“Furthermore, in human T cells, FOXP3 is expressed in non-suppressive Teff cells shortly after T cell receptor (TCR) stimulation (e.g., with anti-CD3) [45–47] (Table 1).”
BackgroundPresser, D., Sester, U., Mohrbach, J., Janssen, M., Köhler, H., & Sester, M. (2009) · Kidney International · doi:10.1038/ki.2009.198 · Cited by 55
Yang, Y., Liu, Y.-J., Tang, S., Yang, L., Yang, J., Cao, G., Zhang, J., Wang, X., & Mao, Y.-Z. (2013) · Pediatric Surgery International · doi:10.1007/s00383-013-3421-6 · Cited by 51
“We defined the phenotype of Treg cells as CD4 ? CD25 Foxp3 cells, as only CD4 CD25 T cells are consistently Foxp3 positive and highly suppressive, while CD4 CD25 T cells also include activated T cells that transiently express Foxp3 and are not suppressive [20].”
BackgroundKoll, F. J., Banek, S., Kluth, L., Köllermann, J., Bankov, K., Chun, F. K.-H., Wild, P. J., Weigert, A., & Reis, H. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03949-3 · Cited by 47
The Role of Regulatory T Cells in the Pathogenesis of Sepsis and Its Clinical Implication
Jiang, L., Yao, Y.-M., & Sheng, Z.-Y. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0080 · Cited by 48
Long, S. A., Walker, M. R., Rieck, M., James, E., Kwok, W. W., Sanda, S., Pihoker, C., Greenbaum, C., Nepom, G. T., & Buckner, J. H. (2009) · European Journal of Immunology · doi:10.1002/eji.200838819 · Cited by 46
“Persistent expression of FOXP3 is associated with regulatory function [33] while transient expression of FOXP3 is associated with activation as demonstrated by co-expression of IFN-γ [34,35].”
BackgroundGarden, O. A., Pinheiro, D., & Cunningham, F. M. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.003 · Cited by 57
Hepatocytes Delete Regulatory T Cells by Enclysis, a CD4+ T Cell Engulfment Process
Davies, S. P., Reynolds, G. M., Wilkinson, A. L., Li, X., Rose, R. E., Leekha, M., Liu, Y. S., Gandhi, R., Buckroyd, E., Grove, J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.068 · Cited by 49
“Foxp3 in mice is restricted to Treg cells, but in humans it can also emerge following stimulation (Allan et al., 2007; Wang et al., 2007).”
BackgroundShack, L. A., Buza, J., & Burgess, S. C. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0460-2 · Cited by 53
“However, although FOXP3 is currently considered as one of the most speciWc markers for naturally occurring CD4(+)CD25(+) T-regulatory cells, expression of FOXP3 is a normal consequence of CD4(+) T cell activation and is not an exclusive marker of human T-reg [ 51 , 52].”
BackgroundPillai, V., & Karandikar, N. J. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.08.012 · Cited by 55
“Rapid downregulation of FOXP3 in activated T cells have led some to question the suppressive capability of these induced FOXP3-expressing cells without even performing suppression assays on these populations [25,28].”
BackgroundCorrell, A., Tuettenberg, A., Becker, C., & Jonuleit, H. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01055.x · Cited by 45
Sun, W., Li, W.-J., Wu, C. Y., Zhong, H., & Wen, W. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-35 · Cited by 47
“[16] postulated that activated CD4 T cells, but without regulatory activity, could express Foxp3.”
BackgroundChang, C., Wu, S., Kang, Y.-W., Lin, K.-P., Chen, T., Medeiros, L. J., & Chang, K. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpujgmvv6zf4gg · Cited by 50
Regulatory T Cells: An Emerging Player in Radiation-Induced Lung Injury
Guo, T., Zou, L., Ni, J., Zhou, Y., Ye, L., Yang, X., & Zhu, Z.-F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01769 · Cited by 48
Kaur, G., Goodall, J. C., Jarvis, L. B., & Hill Gaston, J. S. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.07.008 · Cited by 45
Tregs in transplantation tolerance: role and therapeutic potential
Cassano, A., Chong, A. S., & Alegre, M. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1217065 · Cited by 52
CD4+CD62L+ Central Memory T Cells Can Be Converted to Foxp3+ T Cells
Zhang, X., Li, X. C., Xiao, X., Sun, R., Tian, Z., & Wei, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077322 · Cited by 48
Lindqvist, C. A., Christiansson, L. H., Thörn, I., Mangsbo, S. M., Paul-Wetterberg, G., Sundström, C., Tötterman, T. H., Simonsson, B., Enblad, G., Frisk, P., et al. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03439.x · Cited by 52
Schmitt, S., Johnson, T., Karakhanova, S., Näher, H., Mahnke, K., & Enk, A. (2009) · Transplantation · doi:10.1097/tp.0b013e3181aed927 · Cited by 47
“Although FoxP3 seems to be expressed predominantly by murine Treg, its expression is not exclusive in human Treg (9).”
BackgroundThe Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.
Zheng, S. G. (2008) · PubMed · Cited by 56
Gertel, S., Polachek, A., Elkayam, O., & Furer, V. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103085 · Cited by 51
FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity
Selliah, N., Zhang, M., White, S., Zoltick, P., Sawaya, B. E., Finkel, T. H., & Cron, R. Q. (2008) · Virology · doi:10.1016/j.virol.2008.08.033 · Cited by 44
“It is possible that the FOXP3 expression in control cells was due either to proliferation of a Treg population, or to prolonged expression of FOXP3 in recently activated T-cells, in response to exogenous IL-2 (Allan et al., 2007; Burchill et al., 2007; Murawski et al., 2006; Zorn et al., 2006).”
The Role of FOXP3 in Regulating Immune Responses
Vent‐Schmidt, J., Han, J. M., MacDonald, K. G., & Levings, M. K. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.811657 · Cited by 51
“For example, as for human Tconv cells [17], mouse Tconv cells have recently been shown to transiently express low levels of FOXP3 in lymphopenic conditions [103].”
BackgroundSelf-citationGao, Y., Lin, F. F., Su, J., Gao, Z., Li, Y., Yang, J., Deng, Z., Liu, B., Tsun, A., & Li, B. (2011) · Genes and Immunity · doi:10.1038/gene.2011.77 · Cited by 48
Yang, M., Liu, Y., Mo, B., Xue, Y., Ye, C., Jiang, Y., Bi, X., Liu, M., Wu, Y., Wang, J., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.2139/ssrn.3228224 · Cited by 43
Low-Dose Tolerance Is Mediated by the Microfold Cell Ligand, Reovirus Protein σ1
Rynda, A., Maddaloni, M., Złotkowska, D., Ochoa‐Repáraz, J., Maślanka, T., Crist, K., Riccardi, C., Barszczewska, B., Fujihashi, K., McGhee, J. R., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5187 · Cited by 45
“A low-level intensity of FoxP3 and its transient expression on activated human CD25 T cells has been previously reported (55).”
BackgroundUse of Epigenetic Modification to Induce FOXP3 Expression in Naïve T Cells
Moon, C., Kim, S. H., Park, K. S., Choi, B. K., Lee, H. S., Park, J. B., Choi, G. S., Kwan, J. H., Joh, J. W., & Kim, S. J. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.02.101 · Cited by 44
Morales-Tirado, V. M., Wichlan, D., Leimig, T., Street, S. E. A., Kasow, K. A., & Riberdy, J. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.11.003 · Cited by 43
“For example, FOXP3 is restricted to murine T cells with regulatory function while all human T lymphocytes transiently express FOXP3 upon TCR stimulation, without necessarily acquiring suppressive function [41].”
BackgroundFood‐allergic infants have impaired regulatory T‐cell responses following in vivo allergen exposure
Dang, T. D., Allen, K. J., Martino, D., Koplin, J. J., Licciardi, P. V., & Tang, M. L. K. (2015) · Pediatric Allergy and Immunology · doi:10.1111/pai.12498 · Cited by 69
“Unlike the suppressive Treg cells, the unstable Foxp3 expression in non-Treg activated T cells occurs as a result of incomplete demethylation of the Foxp3 gene (10) that is required for its suppressive function (20).”
BackgroundAkimova, T., Levine, M. H., Beier, U. H., & Hancock, W. W. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3139-2_4 · Cited by 43
“However, in addition to Tregs, activated human effector T (Teffs) cells can upregulate FOXP3 [4], such that phenotypic evaluation of human Tregs using FOXP3 alone is not sufficiently specific for clinical studies.”
BackgroundRegulatory T cells in systemic lupus erythematosus (SLE); Role of peptide tolerance
Sawla, P., Hossain, A., Hahn, B. H., & Singh, R. P. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.09.008 · Cited by 43
“[5, 39, 40] while other studies find no correlation between Foxp3 expression and suppressive capacity [41, 42].”
ResultZhong, Y., Tang, H., Wang, X., Zeng, Q., Liu, Y., Zhao, X., Yu, K., Shi, H., Zhu, R., & Mao, X. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12726 · Cited by 43
Subpopulations of equine blood lymphocytes expressing regulatory T cell markers
Robbin, M. G., Wagner, B., Noronha, L. E., Antczak, D. F., & de Mestre, A. M. (2010) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2010.11.020 · Cited by 42
Nakagawa, K., Tanaka, K., Homma, Y., Nojiri, K., Kumamoto, T., Takeda, K., & Endo, I. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3974-1 · Cited by 44
“We recognize that FoxP3 is not a perfect marker for Tregs in humans.(37,38) In addition, treatmentrelated variables such as NAC may have impacted the outcomes of certain patients.”
BackgroundEnvironmental influences on T regulatory cells in inflammatory bowel disease
Hardenberg, G., Steiner, T. S., & Levings, M. K. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.012 · Cited by 52
Self-citationYip, W. K., Abdullah, M. A., Yusoff, S. M., & Seow, H. F. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03793.x · Cited by 42
Schiavinato, J. L. D. S., Haddad, R., Saldanha‐Araújo, F., Baiochi, J. F., Araújo, A. G., Scheucher, P. S., Covas, D. T., Zago, M. A., & Panepucci, R. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-03456-8 · Cited by 50
Berntsen, A., Brimnes, M. K., Straten, P. T., & Svane, I. M. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181cd870f · Cited by 44
Rodríguez‐Pinto, D., Navas, A., Blanco, V. M., Ramírez, L. G., Garcerant, D., Cruz, A. R., Craft, N. A., & Saravia, N. G. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001627 · Cited by 42
Alvarez-Salazar, E. K., Cortés-Hernández, A., Alemán-Muench, G. R., Alberú, J., Rodríguez‐Aguilera, J. R., Targa, F. R., de Sánchez, V. C., Cuevas, E., Mancilla-Urrea, E., García, M. P., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00219 · Cited by 42
“By contrast, analysis of Tregs in other studies was based on CD25 and FOXP3 expression (9), two markers that are transiently expressed in activated humans T cells (22), and other results were limited by the small numbers of patients included in the study (21).”
Forkhead box P3: The Peacekeeper of the Immune System
Passerini, L., de Sio, F. R. S., Roncarolo, M. G., & Bacchetta, R. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.863303 · Cited by 47
“Also in humans, activation-induced expression of FOXP3 in CD4+CD25− Teff cells is transient and does not necessarily result in the acquisition of suppressive properties [33, 34], although it has been associated with suppression of the cytokine production and proliferation of multiple CD4+ T cell lineages [33, 35].”
BackgroundSelf-citationRole of regulatory T-cells in autoimmunity
Mellanby, R. J., Thomas, D., & Lamb, J. R. (2009) · Clinical Science · doi:10.1042/cs20080200 · Cited by 50
Bontkes, H. J., Ruben, J. M., Alhan, C., Westers, T. M., Ossenkoppele, G. J., & van de Loosdrecht, A. A. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.03.026 · Cited by 42
Wiśniewski, J., Commins, S. P., Agrawal, R., Hulse, K. E., Yu, M. D., Cronin, J. A., Heymann, P. W., Pomés, A., Platts‐Mills, T. A. E., Workman, L., et al. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12537 · Cited by 39
Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation
Narula, M., Lakshmanan, U., Borna, Š., Schulze, J., Holmes, T. H., Harre, N., Kirkey, M., Ramachandran, A., Tagi, V. M., Barzaghi, F., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.09.013 · Cited by 43
Self-citationOkabayashi, T., Cameron, A. M., Hisada, M., Montgomery, R. A., Williams, G. M., & Sun, Z. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03698.x · Cited by 39
“After being activated, conventional human CD4 (+) T cells transiently up-regulate Foxp3 without acquiring a regulatory function (27).”
BackgroundRegulatory T cell therapy as individualized medicine for asthma and allergy
Xystrakis, E., Urry, Z., & Hawrylowicz, C. M. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282f14d7c · Cited by 41
Pillai, V., & Karandikar, N. J. (2008) · Blood · doi:10.1182/blood-2007-09-111823 · Cited by 38
Adult T Cell Leukemia/Lymphoma: FoxP3+ Cells and the Cell-Mediated Immune Response to HTLV-1
Bangham, C. R. M., & Toulza, F. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-385524-4.00004-0 · Cited by 40
“Perhaps FoxP3 expression in these cells is caused by Tax protein-induced T-cell activation (Allan et al., 2007; Wang et al., 2007).”
BackgroundXiao, J., Liu, C., Li, G., Peng, S., Hu, J. N., Qu, L., Lv, P., Zhang, Y., Ma, D., & Chen, Y. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.08.002 · Cited by 38
Low-Dose Antigen Promotes Induction of FOXP3 in Human CD4+ T Cells
Long, S. A., Rieck, M., Tatum, M., Bollyky, P. L., Wu, R. P., Muller, I., Ho, J.-C., Shilling, H. G., & Buckner, J. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003880 · Cited by 49
“tion, and a lack of suppression was observed (51, 57, 58).”
BackgroundHope, C. M., Welch, J., Mohandas, A. P., Pederson, S., Hill, D. L., Gundsambuu, B., Eastaff‐Leung, N., Grosse, R., Bresatz, S., Ang, G., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201948094 · Cited by 39
Regulatory T cells: the future of autoimmune disease treatment
Ryba-Stanisławowska, M. E., Sakowska, J., Zieliński, M., Ławrynowicz, U., & Trzonkowski, P. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1620602 · Cited by 39
Shao, Y., Li, C., Zhang, W., Duan, X., Li, Y., Han, Q., & Jin, C. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.07.019 · Cited by 39
Histone deacetylase inhibitors and transplantation
Tao, R., de Zoeten, E. F., Özkaynak, E., Wang, L., Li, B., Greene, M. I., Wells, A. D., & Hancock, W. W. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.015 · Cited by 38
Bjerg, L., Brosbøl-Ravnborg, A., Tørring, C. W., Dige, A. K., Bundgaard, B. B., Petersen, T., & Höllsberg, P. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.04.012 · Cited by 41
“, 2005), although Foxp3 can be induced in vitro in T cells that are not necessarily suppressive (Allan et al., 2007; Tran et al., 2007).”
BackgroundInfluentialRao, V., Saunes, M., Jørstad, S., & Moen, T. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.08.016 · Cited by 37
der Lee, A. J., Rutten, V. P. M. G., Bruijn, J., Willemse, T., & Broere, F. (2014) · Veterinary Dermatology · doi:10.1111/vde.12140 · Cited by 47
Tateosian, N. L., Reiteri, R. M., Amiano, N. O., Costa, M. J., Villalonga, X., Guerrieri, D., & Maffía, P. C. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.03.013 · Cited by 39
Mahic, M., Yaqub, S., Bryn, T., Henjum, K., Eide, D. M., Torgersen, K. M., Aandahl, E. M., & Taskén, K. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507329 · Cited by 37
“This is in line with recent publications that demonstrate a transient induction of TR cells upon activation of CD4 CD25– T cells [11, 13, 14].”
ResultAngerami, M. T., Suárez, G., Vecchione, M. B., Laufer, N., Ameri, D., Ben, G., Pérez, H., Sued, O. G., Salomón, H., & Quiroga, M. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00528 · Cited by 39
“Besides, an enhanced expression of FoxP3 in human activated T lymphocytes has been observed without conferring any regulatory properties to this cell population (5).”
BackgroundLu, C., Wu, C.-J., Chan, C.-C., Nguyen, D. T., Lin, K.-R., Lin, S., Chen, L., Yen, J. J.-Y., & Kuo, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00488 · Cited by 36
“Activation of human CD4+CD25− T cells through TCR stimulation results in transient, low level expression of FOXP3 without conferring suppressive activity (6, 7), indicating that FOXP3 must be constitutively expressed to maintain Treg cell function.”
BackgroundUnravelling the molecular basis for regulatory T‐cell plasticity and loss of function in disease
Sadlon, T. J., Brown, C. Y., Bandara, V., Hope, C. M., Schjenken, J. E., Pederson, S., Breen, J., Forrest, A. R. R., Beyer, M., Robertson, S. A., et al. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1011 · Cited by 42
Age-associated parallel increase of Foxp3+CD4+ regulatory and CD44+CD4+ memory T cells in SJL/J mice
Han, G.-M., Zhao, B., Jeyaseelan, S., & Feng, J.-M. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.05.003 · Cited by 35
“After being fixed and permeabilized with Cytofix/Cytoperm buffer, the cells were further stained with anti-IL-2-FITC and anti-Foxp3-PE.”
InfluentialLiu, Y., Zhu, T., Cai, G., Qin, Y., Wang, W., Tang, G., Zhao, D., & Shen, Q. (2011) · Lupus · doi:10.1177/0961203310392431 · Cited by 37
Rowe, J. H., Stadinski, B. D., Henderson, L. A., de Bruin, L. M. O., Delmonte, O. M., Lee, Y. N., de la Morena, M. T., Goyal, R. K., Hayward, A. R., Huang, C., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.001 · Cited by 35
Cheng, L., Liu, C., Li, F., Wu, B., Min, Z., Chen, P., Zhan, Y., Yang, K., Hua, F., Yuan, L., et al. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.07.001 · Cited by 41
Martin, H., Reuter, S., Dehzad, N., Heinz, A., Bellinghausen, I., Saloga, J., Haasler, I., Korn, S., Jonuleit, H., Buhl, R., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.038 · Cited by 35
Smith, K. A., & Popmihajlov, Z. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00654.x · Cited by 35
“In addition, there has arisen a second type of Treg, an antigen-induced Treg (iTreg), which arises only transiently upon antigen-activation and does not possess the capacity to suppress cytokine expression or effector T-cell proliferation (79, 80).”
BackgroundResultKasow, K. A., Morales-Tirado, V. M., Wichlan, D., Shurtleff, S. A., Abraham, A., Persons, D. A., & Riberdy, J. M. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.07.005 · Cited by 37
“Two notable differences are that all human T cells transiently express FOXP3 without commensurate acquisition of suppressive function [1;17;19;25].”
BackgroundExtension of the CD4+Foxp3+CD25−/lowregulatory T-cell subpopulation in type 1 diabetes mellitus
Zóka, A., Barna, G., Somogyi, A., Műzes, G., Oláh, Á., Al‐Aissa, Z., Hadarits, O., Kiss, K., & Firneisz, G. (2014) · Autoimmunity · doi:10.3109/08916934.2014.992518 · Cited by 37
“Still, some ambiguity remains as the human effector T-cells may also express Foxp3 transiently at low levels upon activation [15].”
BackgroundMochizuki, K., Kawana, S., Yamada, S., Muramatsu, M., Sano, H., Kobayashi, S., Ohara, Y., Takahashi, N., Hakozaki, M., Yamada, H., et al. (2019) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2019.1578843 · Cited by 35
“FoxP3 is considered to be a specific transcription factor for regulatory T cells, although it can be detected transiently in early activated T cells [21, 22].”
BackgroundCD4+CD25+ but not CD4+Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis
Wang, D., Zhang, H., Liang, J., Gu, Z., Zhou, Q., Fan, X., Hou, Y., & Sun, L. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.40 · Cited by 37
CCL22 is involved in the recruitment of CD4+CD25high T cells into tuberculous pleural effusions
Wu, C., Zhou, Q., Xue‐Jun, Q. I. N., Qin, S., & Shi, H. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01719.x · Cited by 34
Regulatory T cells in primary immunodeficiency diseases
Torgerson, T. R., & Ochs, H. D. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282f1a27a · Cited by 34
Regulatory T cell response correlates with the severity of human hantavirus infection
Koivula, T.-T., Tuulasvaara, A., Hetemäki, I., Mäkelä, S., Mustonen, J. T., Sironen, T. A., Vaheri, A. I., & Arstila, T. P. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.11.007 · Cited by 34
Gibson, D. J., Ryan, E. J., & Doherty, G. A. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31829ed7df · Cited by 35
Hester, J., Mills, N., Shankar, S., Carvalho‐Gaspar, M., Friend, P. J., & Wood, K. J. (2011) · Transplantation · doi:10.1097/tp.0b013e31820c85dc · Cited by 37
“Transient up-regulation of FoxP3 in non-Treg cells on activation is well described in the literature (18), and as we demonstrate in this study, Th17 cells are no different from other CD4 T cells in this aspect.”
BackgroundLord, J. D., Shows, D. M., Chen, J., & Thirlby, R. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136485 · Cited by 37
“Whether or not iTregs share the same inhibitory capacity as nTregs is controversial[16,17].”
BackgroundHall, B. M., Tran, G. T., Verma, N. D., Plain, K. M., Robinson, C. M., Nomura, M., & Hodgkinson, S. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00208 · Cited by 38
“FoxP3 expression in mice is a marker of Treg, but in man activated CD4 and CD8 T cells transiently express FoxP3 (21) and can be induced to have prolonged expression of FoxP3 (22).”
BackgroundLim, A. Y. F., French, M. A., & Price, P. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181a74fad · Cited by 34
Tacrolimus Differentially Regulates the Proliferation of Conventional and Regulatory CD4+ T Cells
Kogina, K., Shoda, H., Yamaguchi, Y., Tsuno, N. H., Takahashi, K., Fujio, K., & Yamamoto, K. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0114-z · Cited by 35
“Previous reports showed that the amount of Foxp3 protein per cell in activated CD4 + CD25 - cells was always significantly lower than levels in Treg cells exposed to equivalent activating conditions ( Allan et al., 2007; Tran et al., 2007).”
BackgroundResultXu, W., Ren, M., Ghosh, S., Qian, K., Luo, Z., Zhang, A., Zhang, C., & Cui, J. (2020) · Mediators of Inflammation · doi:10.1155/2020/3645157 · Cited by 32
Transcriptional and Epigenetic Control of Regulatory T Cell Development
Kitagawa, Y., Wing, J. B., & Sakaguchi, S. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.07.011 · Cited by 34
Metadata
- Authors
- Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Vita-Salute San Raffaele University (IT)
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-20
- Volume
- 19
- Issue
- 4
- Pages
- 345-354
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2139019810
- Cited by
- 872
- References
- 39
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 24 · 2023: 21 · 2022: 25 · 2021: 33 · 2020: 22 · 2019: 34 · 2018: 34 · 2017: 36 · 2016: 26 · 2015: 46 · 2014: 62 · 2013: 62 · 2012: 67
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, CD4+CD25+ T cells, T cell activation, T cell proliferation, cytokine production, CD127, interleukin-2, interferon-gamma, immune tolerance, human T cells
- MeSH terms
- CD69 Antigens, Antibodies, Antigens, Differentiation, Antigens, Differentiation, T-Lymphocyte, Cell Line, Cysteine, Flagellin, Humans, Interferon-gamma, Interleukin-2, Lipoproteins, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Cytokines, CD3 Complex, Receptors, Nerve Growth Factor, Clonal Anergy, CD28 Antigens, Receptors, Tumor Necrosis Factor, Coculture Techniques, Lectins, C-Type, Cell Proliferation, T-Lymphocytes, Regulatory, Toll-Like Receptors, Forkhead Transcription Factors, Glucocorticoid-Induced TNFR-Related Protein, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.